Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides

Precious Metals
Battery Metals
Base Metals
Energy
Critical Metals

nasdaq:cytk

POPULAR ARTICLES

NASDAQ:CYTK

pharmaceutical investing

Cytokinetics Starts Phase 2 Clinical Trial for Cardiomyopathy Treatment

pharmaceutical investing

Cytokinetics Announces Start of Phase 2 Clinical Trial of CK-3773274

Cytokinetics and Cure SMA Renew Partnership

LATEST ARTICLES

Cytokinetics Granted European Orphan Designation for Reldesemtiv to Treat Spinal Musclar Atrophy

Cytokinetics Announces Initiation of Phase 1 Clinical Study of AMG 594, a Cardiac Troponin Activator

Cytokinetics Announces Initiation of Phase 1 Clinical Trial of CK-3773274

pharmaceutical investing

Cytokinetics and Astellas Provide Updates Regarding Collaborative Skeletal Muscle Program

Latest News

Galan Lithium Limited: A$20 million Placement to Strategic Partner

Prospectus

A$20 Million Placement to Strategic Partner

Heritage Mining Provides Corporate Update

Cygnus raises $18.3m to accelerate resource growth and mining studies

Featured Stocks

Allied Critical Metals

ACM:CC

Brightstar Resources

BTR:AU

Brunswick Exploration

BRW:TCM

Stallion Uranium

STUD:CC

Harvest Gold

HVG:CC

Finlay Minerals

FYL:CA

More featured stocks